Abstract:Objective. In order to find the best process for the preparation of Chrysophanol-Pluronic F127 nanomicelles in the laboratory, the preparation of Chrysophanol-Pluronic F127 nanomicelles was optimized using the central composite design method. In order to investigate the properties of the prepared Chrysophanol-Pluronic F127 nanomicelles, physicochemical properties were examined and in vitro dissolution experiments were performed, and the pharmacokinetics of Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were investigated in rabbits. Methods. In the preexperimental study, the best physical solubilization method and organic solvent for Chrysophanol were selected. The ratio of drug dosage to excipient dosage and the amount of organic solvents were evaluated by single-factor test. Based on the single-factor test, the optimal prescription was obtained by screening the formulation and optimizing the preparation process using the central composite design method with the encapsulation efficiency as the index. Chrysophanol-Pluronic F127 nanomicelles were prepared according to the optimal prescription, and their particle size, potential, appearance, and in vitro release experiments were carried out. Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were injected intravenously through the ear margins to rabbits, and the drug concentrations in the blood were measured at different time points by HPLC. The obtained blood concentration data were fitted with PK Solver 2.0 program to obtain pharmacokinetic parameters. Results. In the preexperimental study, ultrasonic method was selected as the physical solubilization method, and acetone was selected as the organic solvent. In single-factor test, the highest encapsulation efficiency was achieved when the ratio of drug dosage to excipient dosage was 1 : 15; the highest encapsulation efficiency was achieved when the amount of organic solvent (acetone) was 8 mL. The equation fitted to the model for the optimized prescription by the central composite design method is as follows: R 1 = − 166.93629 + 16.86478 A + 32.55582 B − 0.169750 AB − 0.482675 2 − 2.25797 B 2 R 2 = 0.9457 . The best prescription for the preparation of Chrysophanol-Pluronic F127 nanomicelles was obtained in the ratio of drug dosage to excipient dosage of 1 : 16.309 and the dosage of organic solvent was 6.595 mL. The prepared nanomicelles have a particle size of 152.8 nm and a potential of -23.9 mV. It was observed by transmission electron microscope that the prepared nanomicelles are uniform and spherical in appearance. The drug metabolism of Chrysophanol and nanomicelles in rabbits conforms to the two-compartment open model, and both of them show linear kinetics in the drug dose range. T 1 / 2 α was 0.31 ± 0.21 h and 0.47 ± 0.35 -Abstract Truncated-

Optimizing the Preparation of Thymopentin Loaded Oral N-trimethyl Chitosan Nanoparticles by Central Composite Design

Research on Thymopentin Loaded Oral N-trimethyl Chitosan Nanoparticles.

[Research on Thymopentin-Loaded N-trimethyl Chitosan Nanoparticles Administered Through Mouth].

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Preparation and Characterization of Thymopentin Loaded Trimethyl Chitosan Submicron

Preparation and Physical Characterization of Poly-Lactic-co-glycolic Acid Nanoparticles Loaded with Thymopentin for Oral Administration

Preparation of pDNA-Loaded Thiolated Chitosan Nanoparticles and Optimization by Using Box-Behnken Design and Response Surface Method

Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.

Study on Central Composite Design Method to Optimize the Preparation Process of Chrysophanol-Pluronic F127 Nanomicelles and Pharmacokinetics

Study on Preparation Release in Vitro and Biological Activity of Thymopentin-Loaded Ph-Sensitive Chitosan Nanoparticles for Oral Administration

Preparation and In Vitro and In Vivo Evaluation Of Panax Notoginseng Saponins-loaded Nanoparticles Coated with Trimethyl Chitosan Derivatives

Two modelling data analytical methods applied to optimise the preparation of norcantharidin chitosan nanoparticles

Preparation and Stability Analysis of Capsaicin-Loaded Thiolated Chitosan-Zein Nanoparticles

Design and formulation of trimethylated chitosan-graft-poly(ε-caprolactone) nanoparticles used for gene delivery.

Preparation of Nattokinase-loaded Trimethyl Chitosan Nanoparticles and Study on Its Release Rate in vitro

Preparation, optimisation, and properties of O-carboxymethyl chitosan-g-cholesterol succinic acid monoester polymer nanomicelles

Synthesis and Optimization of Chitosan Nanoparticles Loaded with L-Ascorbic Acid and Thymoquinone

Preparation and Evaluation of Poly-Butylcyanoacrylate Nanoparticles for Oral Delivery of Thymopentin

Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box–Behnken design

A Novel Bottom-Up Process to Produce Thymopentin Nanoparticles and Their Formulation Optimization

Preparation,characterization and cytotoxicity evaluation of polymeric nanomicelles based on modified chitosan